These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1923589)

  • 1. Microbial lung infections: new therapeutic strategies.
    Döring G
    Pathol Biol (Paris); 1991 Jun; 39(6):587-91. PubMed ID: 1923589
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudomonas in cystic fibrosis sylph or sycophant?
    Fick RB
    Clin Chest Med; 1981 Jan; 2(1):91-102. PubMed ID: 7030601
    [No Abstract]   [Full Text] [Related]  

  • 3. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
    Hodson ME; Wingfield HJ; Batten JC
    Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Azlocillin in the treatment of pulmonary infections in patients with cystic fibrosis: plasma concentrations and therapeutic indications].
    Rosselli P; Marianelli L; Valenza T; Bartolozzi G
    Pediatr Med Chir; 1989; 11(4):389-91. PubMed ID: 2694104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
    Hawley HB; Lewis RM; Swartz DR; Gump DW
    Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Kerrebijn KF; Mouton J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):28-33. PubMed ID: 2130712
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymorphonuclear leukocyte elastase: its effects on the pathogenesis of Pseudomonas aeruginosa infection in cystic fibrosis.
    Döring G
    Antibiot Chemother (1971); 1989; 42():169-76. PubMed ID: 2688543
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bronchial mucins and infection in cystic fibrosis].
    Lamblin G; Ramphal R
    Pathol Biol (Paris); 1991 Jun; 39(6):592-7. PubMed ID: 1923590
    [No Abstract]   [Full Text] [Related]  

  • 9. Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol.
    Mukhopadhyay S; Singh M; Ogston S; Ryan G; Smyth R
    J R Soc Med; 1998; 91 Suppl 34(Suppl 34):25-9. PubMed ID: 9709385
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987.
    Michel BC
    Chest; 1988 Aug; 94(2 Suppl):129S-140S. PubMed ID: 3293939
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhaled tobramycin (TOBI).
    Bonsignore CL
    Pediatr Nurs; 1998; 24(3):258-9. PubMed ID: 9987427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of antibiotics in chronic pulmonary pseudomonas infection.
    Høiby N; Giwercman B; Jensen ET; Pedersen SS; Koch C; Kharazmi A
    Adv Pharmacol; 1994; 30():53-84. PubMed ID: 7833297
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase.
    Bainbridge T; Fick RB
    J Lab Clin Med; 1989 Dec; 114(6):728-33. PubMed ID: 2512365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on treatment of pulmonary exacerbations in cystic fibrosis.
    Smyth A
    Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
    Meyer KC; Zimmerman J
    J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis.
    Prince AS; Neu HC
    J Pediatr; 1980 Jul; 97(1):148-51. PubMed ID: 6445961
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudomonas aeruginosa and the airways disease of cystic fibrosis.
    Hata JS; Fick RB
    Clin Chest Med; 1988 Dec; 9(4):679-89. PubMed ID: 3148384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis.
    Madsen V; Lind A; Rasmussen M; Coulthard K
    J Cyst Fibros; 2004 Dec; 3(4):249-51. PubMed ID: 15698943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of aminoglycosides pharmacokinesis in C.F. patients in relation with certain clinical parameters.
    Douchain F; Lebas L; Houdas S; Chivet C; Bakhache P; Pautard JC
    Acta Univ Carol Med (Praha); 1990; 36(1-4):37-9. PubMed ID: 2130714
    [No Abstract]   [Full Text] [Related]  

  • 20. Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.
    Goldfarb J; Stern RC; Reed MD; Yamashita TS; Myers CM; Blumer JL
    Am J Med; 1987 Apr; 82(4A):174-9. PubMed ID: 3555032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.